In which of these gene parts - exon, intron, promoter, UTR - would we have the possibility of finding a pathogenic variant when sequencing the whole genome of a patient but not when sequencing their exome?
Added by Sonia P.
Step 1
Pathogenic variants in exons can directly affect the structure and function of the resulting protein, leading to disease. Show more…
Show all steps
Your feedback will help us improve your experience
Marlyn Joyce and 72 other Biology educators are ready to help you.
Ask a new question
Labs
Want to see this concept in action?
Explore this concept interactively to see how it behaves as you change inputs.
Key Concepts
Recommended Videos
Using full genome sequencing allows us to be able to: A. determine new medical treatments. B. see how different species are related through evolution. C. All of these D. compare individuals of the same species.
Marlyn J.
Whole Exome Sequencing (WES) is becoming a procedure to help physicians identify the cause of a genetic condition that has defied diagnosis by traditional means. The implication here is that exons in the nuclear genome are sequenced in the hopes that, by comparison with the genomes of nonaffected individuals, a diagnosis might be revealed. (a) What are the strengths and weaknesses of this approach? (b) If you were ordering WES for a patient, would you also include an analysis of the patient's mitochondrial genome?
Jessica W.
Would you be more likely to find single nucleotide polymorphisms (SNPs) in the protein-coding or in the noncoding DNA of the human genome?
Recommended Textbooks
Biology for AP Courses
Objective Biology for NEET
Introduction to General, Organic and Biochemistry
Transcript
Watch the video solution with this free unlock.
EMAIL
PASSWORD